0001209191-20-056365.txt : 20201030
0001209191-20-056365.hdr.sgml : 20201030
20201030203009
ACCESSION NUMBER: 0001209191-20-056365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201028
FILED AS OF DATE: 20201030
DATE AS OF CHANGE: 20201030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FEES JESSICA
CENTRAL INDEX KEY: 0001760391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38459
FILM NUMBER: 201278733
MAIL ADDRESS:
STREET 1: C/O SURFACE ONCOLOGY, ICN.
STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surface Oncology, Inc.
CENTRAL INDEX KEY: 0001718108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-714-4096
MAIL ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-28
0
0001718108
Surface Oncology, Inc.
SURF
0001760391
FEES JESSICA
C/O SURFACE ONCOLOGY, INC.
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Common Stock
2020-10-28
4
M
0
4773
4.136
A
100678
D
Common Stock
2020-10-28
4
M
0
122
4.27
A
100800
D
Stock Option (Right to Buy)
4.136
2020-10-28
4
M
0
4773
0.00
D
2026-12-09
Common Stock
4773
682
D
Stock Option (Right to Buy)
4.27
2020-10-28
4
M
0
122
0.00
D
2029-03-01
Common Stock
122
14078
D
This option shall vest in 48 equal monthly installments after January 1, 2017.
The stock option vests and becomes exercisable in 48 equal monthly installments after November 18, 2018.
Title: Principal Accounting Officer, Principal Financial Officer
/s/ Jessica Fees
2020-10-30